HGH (Somatropin): FDA-approved for specific indications: pediatric growth hormone deficiency, adult GHD, Turner syndrome, HIV/AIDS-related wasting, short bowel syndrome Prescription-only medication requiring physician monitoring Illegal to distribute for off-label purposes including anti-aging (per the 1990 Anabolic Steroids Control Act amendments) Brand names include Genotropin, Norditropin, Humatrope, Saizen CJC-1295 and Ipamorelin: Neither is FDA-approved for any therapeutic indication Available as research compounds for laboratory use only (RUO Research Use Only) Not scheduled substances, but not approved for human therapeutic use Ipamorelin has undergone Phase I/II clinical trials (Johansen et al., 1999) but development did not progress to approval For a deeper look at Ipamorelin's regulatory history, see our Ipamorelin FDA approval status guide

Vithalkar MP, Pradhan S, Sandra KS, Bharath HB, Nayak Y (2025) Modulating NLRP3 inflammasomes in idiopathic pulmonary fibrosis: a comprehensive review on flavonoid-based interventions
Obesity drug mazdutide reduces weight and waist size in major trial Weight loss helps older AF patients slim down, but does not ease symptoms Owing to such statistical anomalies, researchers must ensure a sufficient number of patients are enrolled in clinical trials to know with some certainty that the adverse event is not related to treatment, allowing a lack of correlation to be established within a certain confidence range
Skin Elasticity: Multi Collagen Complex (Type I & III) and essential electrolytes support hydration and performance